Biology, Genetics & Inheritance

Understanding the biological roots of Citrullinemia Type I (CTLN1) can help you navigate your child’s care with more confidence. This condition is not caused by anything a parent did or didn’t do; it is a fundamental difference in how the body processes protein at a molecular level ^[1].

The Urea Cycle: Your Body’s Waste System

Every time we eat protein, our bodies break it down into amino acids. A byproduct of this process is ammonia, which is highly toxic, especially to the brain ^[2][3]. Healthy bodies use a series of chemical reactions called the urea cycle to turn this toxic ammonia into urea, which is safely passed out of the body in urine ^[2][1].

The Role of the ASS1 Gene

The ASS1 gene provides the instructions for making an enzyme called argininosuccinate synthetase 1 ^[2]. In the urea cycle, this enzyme acts like a specialized worker on an assembly line. Its specific job is to combine two substances—citrulline and aspartate—to create argininosuccinate ^[2][4].

When the ASS1 gene has a mutation (a “glitch” in its code), the assembly line stops at this step. Because the worker (the enzyme) isn’t there or isn’t working correctly:

• Citrulline builds up in the blood because it has nowhere to go ^[1].
• Ammonia backs up behind it, reaching toxic levels ^[1].

How It Is Inherited

Citrullinemia Type I follows an autosomal recessive inheritance pattern. This means a child must inherit two “glitched” copies of the ASS1 gene—one from each parent—to have the condition ^[1][5].

[Insert Visual Infographic Here: 25/50/25 Autosomal Recessive Inheritance Probabilities]

• Carriers: Parents are typically “carriers.” They have one working gene and one glitched gene. Because their working gene produces enough enzyme to handle the urea cycle, they usually have no symptoms ^[5].
• The 25% Rule: When two carriers have a child, there is a:
  • 25% chance the child will have CTLN1 (inheriting two glitched genes).
  • 50% chance the child will be a carrier like their parents.
  • 25% chance the child will inherit two working genes.

The Spectrum of Severity: Residual Activity

Not every mutation in the ASS1 gene is the same. The severity of the disease often depends on residual enzyme activity—how much the “worker” can still do despite the glitch ^[6].

• Classic Form: Some mutations (like the common p.Gly390Arg variant) result in almost zero enzyme activity ^[7]. This leads to the “classic” neonatal form where symptoms appear days after birth ^[3].
• Late-Onset Form: Other mutations might leave the enzyme with a small amount of function (often more than 8% of normal) ^[6]. These individuals may not have a crisis until they face a trigger like a high-protein meal or a severe illness ^[6][8].
• Substrate Affinity: In some cases, the enzyme is present but doesn’t “grab” its fuel (citrulline and aspartate) well ^[9]. Research suggests that for certain specific mutations, providing high doses of these substances might help the enzyme work a little better ^[9].

While genetic testing can give us clues about what to expect, every person is unique. Even identical twins with the same mutations can sometimes have different symptoms, showing that other factors in the body and environment also play a role ^[10].

Return to Home Page